-
<![CDATA[A Look at Lynkuet® (Elinzanetant) for the Treatment of Moderate to Severe Vasomotor Symptoms]]>
05 Nov 2025 18:21 GMT
… lower doses) and no further benefit of the 160-mg dose … ® (elinzanetant) [Prescribing Information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc.; October 2025
Sassarini …
-
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
28 May 2025 12:29 GMT
… with valuable insights into the benefits of combining XOFIGO with … known radiographic progression free survival benefit. We are encouraged by … Injection [Prescribing Information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, December 2019.
Choudhury A …
-
Effect of Recombinant Human Brain Natriuretic Peptide Therapy After PCI in Patients with Acute Myocardial Infarction and Its Impact on Cardiac Function: A Retrospective Controlled Study
03 Nov 2025 19:12 GMT
… randomized trials have suggested potential benefits of rhBNP in improving hemodynamics … tablets (100 mg/d, Bayer Healthcare Co., Ltd., NMPA Approval No … rhBNP to confer lasting cardiovascular benefits by simultaneously addressing myocardial injury …
-
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A
04 Mar 2025 03:23 GMT
… levels has demonstrated considerable clinical benefit.2 Such maintenance requires … was the lack of perceived benefit from treatment. Because prophylaxis … Information.pdf.
Kovaltry. Prescribing information. Bayer Healthcare; 2022. Accessed November 27, 2024 …
-
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.
13 Jan 2025 11:03 GMT
Alkaline phosphatase (ALP) declines and pain responses can occur during radium-223 (223Ra) treatment, but their association with treatment outcomes is unclear.
For patients with metastatic castration-resistant prostate cancer treated with 223Ra in the …
-
<![CDATA[Estrogen-Based MHT Does Not Consistently Reduce Anxiety Symptoms in Midlife Women]]>
24 Oct 2025 16:02 GMT
… Pharmacy Times in partnership with Bayer Healthcare.
Estrogen-based menopausal hormone … are more likely to benefit from estrogen-based MHT … They emphasized that modest benefits may be seen in perimenopausal … are most likely to benefit from estrogen-based MHT …
-
<![CDATA[Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025]]>
24 Oct 2025 16:02 GMT
… Pharmacy Times in partnership with Bayer Healthcare.
Perceptions, understanding, and … with symptoms, the benefits of hormone therapy typically … in 2025 believing the benefits outweigh the risks (2021 … around the risks and benefits of hormone therapy. …
-
<![CDATA[MHT Use Can Affect Cognitive Health Depending on Administration Method]]>
22 Oct 2025 18:10 GMT
… Times in partnership with Bayer Healthcare.
Menopausal hormone therapy (MHT … had no overall sustained benefit or risk to … not associated with cognitive benefits compared to those who … with episodic memory potentially benefiting from greater ER activation …
-
<![CDATA[Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations]]>
21 Oct 2025 20:15 GMT
… Pharmacy Times in partnership with Bayer Healthcare.
When treating women across different … , 120 mg of elinzanetant (Bayer Healthcare) reduced the frequency and severity … elinzanetant to provide meaningful clinical benefit to women pending regulatory approval …
-
Animal Growth Promoters And Performance Enhancers Market is Forecasted to Reach a Value of US $20.71 Billion by 2029
17 Oct 2025 09:30 GMT
… . This is predicted to mutually benefit and propel the market for … Inc.
• Alltech Biotechnology Pvt. Ltd.
• Bayer HealthCare Animal Health Inc.
• Zoetis Inc …
About
© 1995-2025